Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Sun Pharmaceutical Industries Ltd.
NSE: SUNPHARMA
|
BSE: 524715
|
ISIN: INE044A01036
|
Industry: Pharmaceuticals
|
Falling Comet
1586.4000
-12.00
(
-0.75
%)
NSE
Aug 08, 2025
12:37 PM
Near 52W Low of ₹1553.05
Volume:
665.3K
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Sun Pharmaceutical Industries Ltd.
edited
19 Mar 2024
1586.40
-0.75%
Sun Pharma Gets Regulatory Nod In Australia For Acne Treatment Cream
NDTV Profit
Sun Pharma has received regulatory approval in Australia for its acne treatment cream, Winlevi.
Geojit BNP Paribas upgraded Sun Pharmaceutical Industries Ltd. to Buy with a price target of 1830.0 on 05 Aug, 2025.
Buy Sun Pharmaceuticals; target of Rs 1827: KR Choksey
Moneycontrol |
20 Mar 2024
4 more
Sun Pharma Gets Regulatory Nod In Australia For Acne Treatment Cream
NDTV Profit |
19 Mar 2024
Sun Pharma gets regulatory nod in Australia for acne treatment cream
Moneycontrol |
19 Mar 2024
Sun Pharmaceuticals receives approval for Winlevi in Australia
Business Line |
19 Mar 2024
Sun Pharma - Global Specialty Sales To Get A Boost From Addition Of Australian Geography: DRChoksey
NDTV Profit |
20 Mar 2024
More from Sun Pharmaceutical Industries Ltd.
Recommended
Market trades lower, Ramco Cements' Q1FY26 net profit misses Forecaster estimates by 7.1%
Trendlyne Marketwatch |
08 Aug 2025, 12:31PM
Chart of the Week: Mutual funds and FIIs bet big on 11 Nifty 500 stocks in Q1FY26
The Baseline |
07 Aug 2025, 05:53PM
Change is hard, and some Indian pharma companies are embracing it better than others
|
09 Aug 2022